Xiongfeng Cao
- Cancer Research top 10%
- MicroRNA in disease regulation 2
-
- Ferroptosis and cancer prognosis 4
-
- Nanoparticle-Based Drug Delivery 5
-
- RNA modifications and cancer 4
-
- Immune cells in cancer 2
-
- Nanoplatforms for cancer theranostics 4
-
- Mesoporous Materials and Catalysis 2
-
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Haitao ZhuAihua GongDongqing WangKang WangMing WangZhengyang ZhangYanfang LiuSong Lian
In The Last Decade
Xiongfeng Cao
12 papers receiving 484 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 179
- Pulmonary and Respiratory Medicine 221
- Biomaterials 62
- Molecular Biology 260
- Immunology 54
Countries citing papers authored by Xiongfeng Cao
This map shows the geographic impact of Xiongfeng Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiongfeng Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiongfeng Cao more than expected).
Fields of papers citing papers by Xiongfeng Cao
This network shows the impact of papers produced by Xiongfeng Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiongfeng Cao. The network helps show where Xiongfeng Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiongfeng Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 15 | |
| 3 | 2022 | 18 | |
| 4 | 2022 | 46 | |
| 5 | 2020 | 29 | |
| 6 | 2020 | 171 | |
| 7 | 2020 | 16 | |
| 8 | 2019 | 10 | |
| 9 | 2019 | 43 | |
| 10 | 2019 | 70 | |
| 11 | 2018 | 35 | |
| 12 | 2018 | 34 |
About Xiongfeng Cao
Xiongfeng Cao is a scholar working on Biomaterials, Cancer Research and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 488 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (4 papers), Nanoplatforms for cancer theranostics (4 papers), Mesoporous Materials and Catalysis (2 papers), Immune cells in cancer (2 papers), MicroRNA in disease regulation (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Cancer Research (179 citations), Pulmonary and Respiratory Medicine (221 citations) and Biomaterials (62 citations). Xiongfeng Cao has collaborated with scholars based in China, Australia and Canada. Frequent co-authors include Haitao Zhu, Aihua Gong, Dongqing Wang, Kang Wang, Ming Wang, Zhengyang Zhang, Yanfang Liu, Song Lian, Zhaogang Teng and Fang Cheng. Their work appears in journals such as Biomaterials, ACS Applied Materials & Interfaces and Journal of Colloid and Interface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.